THE UK has become the first country in Europe to approve a daily weight loss pill made by the same company as Mounjaro. The MHRA previously approved the oral version of Wegovy (semaglutide) for weight management in June 2026, making Foundayo the second GLP-1 receptor agonist tablet approved for weight management in the UK. NHS Availability Still to Be DecidedAlthough Foundayo has received regulatory approval, its availability through the NHS for weight management is a separate decision. Could Foundayo Help Maintain Weight Loss? In trials, the drug showed benefits in comparison to weight loss jabs for helping patients maintain weight loss in the long-term after moving away from injectable GLP-1 treatments.